A fifth coronavirus vaccine candidate is now in the final stage of testing.
Novavax is looking for some 30,000 volunteers for its study.
It will focus on high-risk older adults and volunteers from Black and Hispanic communities, which have been among the hardest-hit by the pandemic.
Two-thirds of volunteers will get the vaccine; the rest will get a placebo.
